5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dementia in Parkinson's disease.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dementia can occur in a substantial number of patients with Parkinson's disease with a point prevalence close to 30%. The cognitive profile is characterized by predominant deficits in executive, visuospatial functions, attention and memory. Behavioral symptoms are frequent such as apathy, visual hallucinations and delusions. The most prominent associated pathology is Lewy body-type and biochemical deficit is cholinergic. Placebo-controlled randomized trials with cholinesterase inhibitors demonstrated modest but significant benefits in cognition, behavioral symptoms and global functions.

          Related collections

          Author and article information

          Journal
          J. Neurol. Sci.
          Journal of the neurological sciences
          Elsevier BV
          1878-5883
          0022-510X
          Mar 15 2017
          : 374
          Affiliations
          [1 ] Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey. Electronic address: hasmet@yahoo.com.
          [2 ] Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul, Turkey.
          Article
          S0022-510X(17)30014-X
          10.1016/j.jns.2017.01.012
          28088312
          aac5065a-08ce-424e-87bc-9ff56f3d8592
          History

          Cholinesterase inhibitors,Parkinson's disease,Dementia with Lewy Bodies,Dementia

          Comments

          Comment on this article